Identification of serum biomarkers in brain-injured adults: Potential for predicting elevated intracranial pressure

Journal of Neurotrauma

Volumn 25, Issue 2, 2008, Pages 79-93

  Hergenroeder, Georgene ^a   Redell, John B ^a   Moore, Anthony N ^a   Dubinsky, William P ^a   Funk, Robert T ^a   Crommett, John ^a   Clifton, Guy L ^a   Levine, Robert ^a   Valadka, Alex ^a   Dash, Pramod K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Biomarker; C reactive protein; Intracranial pressure; Retinol binding protein 4; Secondary pathology; Serum amyloid protein A

Indexed keywords

AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; RETINOL BINDING PROTEIN 4;

ADOLESCENT; ADULT; AGED; ARTICLE; AXONAL INJURY; BLOOD SAMPLING; BRAIN CONTUSION; BRAIN EDEMA; BRAIN HEMORRHAGE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDURAL HEMATOMA; FEMALE; GLASGOW COMA SCALE; HUMAN; INJURY SEVERITY; INTRACRANIAL PRESSURE; LIQUID CHROMATOGRAPHY; MALE; OUTCOME ASSESSMENT; PNEUMOCEPHALUS; QUANTITATIVE ANALYSIS; RISK REDUCTION; SCREENING; SENSITIVITY AND SPECIFICITY; SKULL FRACTURE; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; TANDEM MASS SPECTROMETRY; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRAIN INJURIES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INDICATORS AND REAGENTS; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETINOL-BINDING PROTEINS, PLASMA; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 39149098117     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2007.0386     Document Type: Article

References (48)

1. Anderson, N.L., and Anderson, N.G. (2002). The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics 1, 845-867.
2. Bazarian, J.J., Zemlan, F.P., Mookerjee, S., and Stigbrand, T. (2006). Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Inj. 20, 759-765.
3. Beers, S.R., Berger, R.P., and Adelson, P.D. (2007). Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. J. Neurotrauma 24, 97-105.
4. Berger, R.P. (2006). The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J. Head Trauma Rehabil. 21, 315-333.
5. Berger, M.S., Pitts, L.H., Lovely, M., Edwards, M.S., and Bartkowski, H.M. (1985). Outcome from severe head injury in children and adolescents. J. Neurosurg. 62, 194-199.
6. Berger, R.P., Pierce, M.C., Wisniewski, S.R., Adelson, P.D., and Kochanek, P.M. (2002). Serum S100B concentrations are increased after closed head injury in children: a preliminary study. J. Neurotrauma 19, 1405-1409.
7. Berger, R.P., Adelson, P.D., Richichi, R., and Kochanek, P.M. (2006a). Serum biomarkers after traumatic and hypoxemic brain injuries: insight into the biochemical response of the pediatric brain to inflicted brain injury. Dev. Neurosci. 28, 327-335.
8. Berger, R.P., Dulani, T., Adelson, P.D., Leventhal, J.M., Richichi, R., and Kochanek, P.M. (2006b). Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: a possible screening tool. Pediatrics 117, 325-332.
9. Boehm, A.M., Puetz, S., Altenhofer, D., Sickmann, A., and Falk, M. (2007). Precise protein quantification based on peptide quantification using iTRAQ. BMC. Bioinform. 8, 214.
10. Borovecki, F., Lovrecic, L., Zhou, J., Jeong, H., Then, F., Rosas, H.D., Hersch, S.M., Hogarth, P., Bouzou, B., Jensen, R.V., and Krainc, D. (2005). Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 102, 11023-11028.
11. Clifton, G.L., Miller, E.R., Choi, S.C., Levin, H.S., McCauley, S., Smith, K.R., Jr., Muizelaar, J.P., Wagner, F.C., Jr., Marion, D.W., Luerssen, T.G., Chesnut, R.M., and Schwartz, M. (2001). Lack of effect of induction of hypothermia after acute brain injury. N. Engl. J. Med. 344, 556-563.
12. Eastham, J.A. (2005). Prostate-specific antigen doubling time as a prognostic marker in prostate cancer. Nat. Clin. Pract. Urol. 2, 482-491.
13. Gottesfeld, Z., Moore, A.N., and Dash, P.K. (2002). Acute ethanol intake attenuates inflammatory cytokines after brain injury in rats: a possible role for corticosterone. J. Neurotrauma 19, 317-326.
14. Haqqani, A.S., Hutchison, J.S., Ward, R., and Stanimirovic, D.B. (2007). Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. J. Neurotrauma 24, 54-74.
15. Haskins, W.E., Kobeissy, F.H., Wolper, R.A., Ottens, A.K., Kitlen, J.W., McClung, S.H., O'Steen, B.E., Chow, M.M., Pineda, J.A., Denslow, N.D., Hayes, R.L., and Wang, K.K. (2005). Rapid discovery of putative protein biomarkers of traumatic brain injury by SDS-PAGE-capillary liquid chromatography-tandem mass spectrometry. J. Neurotrauma 22, 629-644.
16. Hlatky, R., Furuya, Y., Valadka, A.B., Gonzalez, J., Chacko, A., Mizutani, Y., Contant, C.F., and Robertson, C.S. (2002). Dynamic autoregulatory response after severe head injury. J. Neurosurg. 97, 1054-1061.
17. Hlatky, R., Contant, C.F., Diaz-Marchan, P., Valadka, A.B., and Robertson, C.S. (2004). Significance of a reduced cerebral blood flow during the first 12 hours after traumatic brain injury. Neurocrit. Care. 1, 69-83.
18. Hlatky, R., Valadka, A.B., and Robertson, C.S. (2005). Intracranial pressure response to induced hypertension: role of dynamic pressure autoregulation. Neurosurgery 57, 917-923.
19. Jenkins, L.W., Peters, G.W., Dixon, C.E., Zhang, X., Clark, R.S., Skinner, J.C., Marion, D.W., Adelson, P.D., and Kochanek, P.M. (2002). Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. J. Neurotrauma 19, 715-740.
20. Juul, N., Morris, G.F., Marshall, S.B., and Marshall, L.F. (2000). Intracranial hypertension and cerebral perfusion pressure: influence on neurological deterioration and outcome in severe head injury. The Executive Committee of the International Selfotel Trial. J. Neurosurg. 92, 1-6.
21. Kalsotra, A., Zhao, J., Anakk, S., Dash, P.K., and Strobel, H.W. (2007). Brain trauma leads to enhanced lung inflammation and injury: evidence for role of P4504Fs in resolution. J. Cereb. Blood Flow Metab. 27, 963-974.
22. Knaus, W.A., Draper, E.A., Wagner, D.P., and Zimmerman, J.E. (1985). APACHE II: a severity of disease classification system. Crit. Care Med. 13, 818-829.
23. Lachmann, H.J., Goodman, H.J., Gilbertson, J.A., Gallimore, J.R., Sabin, C.A., Gillmore, J.D., and Hawkins, P.N. (6-7-2007). Natural history and outcome in systemic AA amyloidosis. N. Engl. J. Med. 356, 2361-2371.
24. Lai, Y., Stange, C., Wisniewski, S.R., Adelson, P.D., Janesko-Feldman, K.L., Brown, D.S., Kochanek, P.M., and Clark, R.S. (2006). Mitochondrial heat shock protein 60 is increased in cerebrospinal fluid following pediatric traumatic brain injury. Dev. Neurosci. 28, 336-341.
25. Lewandrowski, K., Chen, A., and Januzzi, J. (2002). Cardiac markers for myocardial infarction. A brief review. Am. J. Clin. Pathol. 118, S93-S99.
26. Liotta, L.A., and Petricoin, E.F. (2006). Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J. Clin. Invest. 116, 26-30.
27. Maier, B., Schwerdtfeger, K., Mautes, A., Holanda, M., Muller, M., Steudel, W. I., and Marzi, I. (2001). Differential release of interleukines 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock 15, 421-426.
28. Maier, B., Laurer, H.L., Rose, S., Buurman, W.A., and Marzi, I. (2005). Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J. Neurotrauma 22, 822-835.
29. Maset, A.L., Marmarou, A., Ward, J.D., Choi, S., Lutz, H.A., Brooks, D., Moulton, R.J., Desalles, A., Muizelaar, J.P., and Turner, H. (1987). Pressure-volume index in head injury. J. Neurosurg. 67, 832-840.
30. Pelinka, L.E., Kroepfl, A., Schmidhammer, R., Krenn, M., Buchinger, W., Redl, H., and Raabe, A. (2004). Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. J. Trauma. 57, 1006-1012.
31. Pieper, R., Su, Q., Gatlin, C. L., Huang, S.T., Anderson, N.L., and Steiner, S. (2003). Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3, 422-432.
32. Pineda, J.A., Wang, K.K., and Hayes, R.L. (2004). Biomarkers of proteolytic damage following traumatic brain injury. Brain Pathol. 14, 202-209.
33. Pineda, J.A., Lewis, S.B., Valadka, A.B., Papa, L., Hannay, H.J., Heaton, S.C., Demery, J.A., Liu, M.C., Aikman, J.M., Akle, V., Brophy, G.M., Tepas, J.J., Wang, K.K., Robertson, C.S., and Hayes, R.L. (2007). Clinical significance of alpha II-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366.
34. Posadas, E.M., Davidson, B., and Kohn, E.C. (2004). Proteomics and ovarian cancer: implications for diagnosis and treatment. A critical review of the recent literature. Curr. Opin. Oncol. 16, 478-484.
35. Shaw, G., Yang, C., Ellis, R., Anderson, K., Parker, Mickle J., Scheff, S., Pike, B., Anderson, D.K., and Howland, D.R. (2005). Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem. Biophys. Res. Commun. 336, 1268-1277.
36. Shore, P.M., Thomas, N.J., Clark, R.S., Adelson, P.D., Wisniewski, S.R., Janesko, K.L., Bayir, H., Jackson, E.K., and Kochanek, P.M. (2004). Continuous versus intermittent cerebrospinal fluid drainage after severe traumatic brain injury in children: effect on biochemical markers. J. Neurotrauma 21, 1113-1122.
37. Shore, P.M., Berger, R.P., Varma, S., Janesko, K.L., Wisniewski, S.R., Clark, R.S., Adelson, P.D., Thomas, N.J., Lai, Y.C., Bayir, H., and Kochanek, P.M. (2007). Cerebrospinal fluid biomarkers versus Glasgow Coma Scale and Glasgow Outcome Scale in pediatric traumatic brain injury: the role of young age and inflicted injury. J. Neurotrauma 24, 75-86.
38. Stocchetti, N., Colombo, A., Ortolano, F., Videtta, W., Marchesi, R., Longhi, L., and Zanier, E.R. (2007). Time course of intracranial hypertension after traumatic brain injury. J. Neurotrauma 24, 1339-1346.
39. Taracha, E., Habrat, B., Chrapusta, S.J., Lehner, M., Wislowska, A., Woronowicz, B.T., Bogulas, M., Charewicz, J., Markuszewski, C., and Plaznik, A. (2006). Combining markers of nephrotoxicity and hepatotoxicity for improved monitoring and detection of chronic alcohol abuse. Clin. Chem. Lab. Med. 44, 1446-1452.
40. Teasdale, G., and Jennett, B. (1974). Assessment of coma and impaired consciousness. A practical scale. Lancet 2, 81-84.
41. Troyer, D.A., Mubiru, J., Leach, R.J., and Naylor, S.L. (2004). Promise and challenge: markers of prostate cancer detection, diagnosis and prognosis. Dis. Markers 20, 117-128.
42. Unterberg, A.W., Stover, J., Kress, B., and Kiening, K.L. (2004). Edema and brain trauma. Neuroscience 129, 1021-1029.
43. Wagner, A.K., Bayir, H., Ren, D., Puccio, A., Zafonte, R.D., and Kochanek, P.M. (2004). Relationships between cerebrospinal fluid markers of excitotoxicity, ischemia, and oxidative damage after severe TBI: the impact of gender, age, and hypothermia. J. Neurotrauma 21, 125-136.
44. Wang, K.K., Ottens, A.K., Liu, M.C., Lewis, S.B., Meegan, C., Oli, M.W., Tortella, F.C., and Hayes, R.L. (2005). Proteomic identification of biomarkers of traumatic brain injury. Expert. Rev. Proteomics 2, 603-614.
45. Wulfkuhle, J.D., Liotta, L.A., and Petricoin, E.F. (2003). Proteomic applications for the early detection of cancer. Nat. Rev. Cancer. 3, 267-275.
46. Yocum, A.K., Yu, K., Oe, T., and Blair, I.A. (2005). Effect of immunoaffinity depletion of human serum during proteomic investigations. J. Proteome Res. 4, 1722-1731.
47. Zemlan, F.P., Jauch, E.C., Mulchahey, J.J., Gabbita, S.P., Rosenberg, W.S., Speciale, S.G., and Zuccarello, M. (2002). C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res. 947, 131-139.
48. Zweig, M.H., and Campbell, G. (1993). Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561-577.